Latest Earnings Results: Q3 '26
Estimated EPS
-$0.14
Reported EPS
-$0.11
Surprise
+22.22%
Estimated Rev
$48.84M
Reported Rev
$44.62M
Surprise
-8.62%
• Reported GAAP EPS of -$0.11 down -10.00% YoY • Reported revenue of $44.63M down -25.83% YoY • LifeMD's Q4 2026 revenue range is $46M, with Adjusted EBITDA -$4M to -$2M; revised FY2026 ranges are revenue $188M and Adjusted EBITDA -$12.6M to -$10.6M.
Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q4 '26 | -$0.16 | -- | -- | N/A |
Q3 '26 | -$0.14 | -$0.11 | 22.22% | BEAT |
Q2 '26 | -$0.15 | -$0.16 | -9.80% | MISSED |
Q1 '26 | -$0.21 | -$0.20 | 2.78% | BEAT |
Q4 '25 | -$0.07 | $0.41 | 723.92% | BEAT |